Loading...

VOR VOR BIOPHARMA INC Management Changes 8-K Filing

VR B

VR

VOR BIOPHARMA INC

(VOR)

2026 8-K

Private Placement Agreement

Financial Update

Management Change

Funding Announcement

Stock Option Repricing

Equity Offering Details

Management Changes

Clinical Trial Data

Stock Split Update

Corporate Presentation Update

Management Changes

Stockholder Approval

Licensing Agreement

Equity Offerings

Workforce Reduction

Noncompliance with Listing ...

Management Change

Stock Option Repricing

Board Appointment

Private Placement

Clinical Data Update

CFO Appointment

Resignation and Appointment

Equity Incentive Plan Amend...

Appointment of Director

Clinical Update

Annual Meeting of Stockholders

Resignation of Director

Clinical Update

External Links:

On December 31, 2025, Vor Biopharma Inc. announced the separation of Dr. Qing Zuraw, Chief Development Officer, who will receive severance benefits and potentially consult during the transition period.

AI Assistant

VOR BIOPHARMA INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.